Letter to the editorManagement of β-agonist overuse: Why and how?
References (11)
- et al.
Beta-adrenergic modulation of human type-1/type-2 cytokine balance
J Allergy Clin Immunol
(2000) - et al.
The beta-agonist controversy
Med Clin North Am
(1996) - et al.
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol
Chest
(2006) - et al.
Managing severe asthma
J Allergy Clin Immunol
(2006) - et al.
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial
Lancet
(2001)
There are more references available in the full text version of this article.
Cited by (0)
Disclosure of potential conflict of interest: D. R. Taylor has received speaker's fees from AstraZeneca New Zealand and Aerocrine AB, Sweden. D. Hannah has declared that she has no conflict of interest.
Copyright © 2008 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.